Based on 1 analyst offering 12 month price targets for Vincerx Pharma Inc
Min Forecast
$40.00+6,072.84%
Avg Forecast
$40.00+6,072.84%
Max Forecast
$40.00+6,072.84%
Should I buy or sell VINC stock?
Based on 1 analyst offering ratings for Vincerx Pharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VINC's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates VINC as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their VINC stock forecasts and price targets.
VINC stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2024-10-08
1 of 1
Forecast return on equity
Is VINC forecast to generate an efficient return?
Company
N/A
Industry
154.62%
Market
89.47%
Forecast return on assets
Is VINC forecast to generate an efficient return on assets?
Company
N/A
Industry
32.61%
VINC earnings per share forecast
What is VINC's earnings per share in the next 1 years based on estimates from 1 analyst?
Is Vincerx Pharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: VINC) stock is to Buy VINC stock.
Out of 1 analyst, 0 (0%) are recommending VINC as a Strong Buy, 1 (100%) are recommending VINC as a Buy, 0 (0%) are recommending VINC as a Hold, 0 (0%) are recommending VINC as a Sell, and 0 (0%) are recommending VINC as a Strong Sell.
What is VINC's earnings growth forecast for 2025-2025?
(NASDAQ: VINC) Vincerx Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.8%.
Vincerx Pharma's earnings in 2025 is -$27,030,000.
In 2025, VINC is forecast to generate -$10,737,888 in earnings, with the lowest earnings forecast at -$10,737,888 and the highest earnings forecast at -$10,737,888.
What is VINC's forecast return on equity (ROE) for 2025-2028?
(NASDAQ: VINC) forecast ROE is N/A, which is considered weak.
What is VINC's Price Target?
According to 1 Wall Street analyst that have issued a 1 year VINC price target, the average VINC price target is $40.00, with the highest VINC stock price forecast at $40.00 and the lowest VINC stock price forecast at $40.00.
The Wall Street analyst predicted that Vincerx Pharma's share price could reach $40.00 by Oct 8, 2025. The average Vincerx Pharma stock price prediction forecasts a potential upside of 6,072.84% from the current VINC share price of $0.65.
What is VINC's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: VINC) Vincerx Pharma's current Earnings Per Share (EPS) is -$20.60. In 2025, VINC's EPS is forecast to hit -$6.40 (min: -$6.40, max: -$6.40).
What is VINC's forecast return on assets (ROA) for 2025-2028?
(NASDAQ: VINC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 32.61%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.